Jimmi Nielsen
Clinical Professor
- 2024
- Published
Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia– a case series
Mølgaard, S. N., Nielsen, Mette Ødegaard, Roed, K. & Nielsen, Jimmi, 2024, In: BMC Psychiatry. 24, 1, 8 p., 240.Research output: Contribution to journal › Journal article › Research › peer-review
- E-pub ahead of print
Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study
Sass, M. R., Christensen, A. M. B., Christensen, M. L., Gruber, E., Nerdrum, H., Pedersen, L. M., Resch, M., Jørgensen, T. H., Ekstrøm, Claus Thorn, Nielsen, Jimmi, Vilsbøll, Tina & Fink-Jensen, Anders, 2024, (E-pub ahead of print) In: Acta Psychiatrica Scandinavica.Research output: Contribution to journal › Journal article › Research › peer-review
- 2023
- Published
Alterations in inflammatory markers after a 12-week exercise program in individuals with schizophrenia—a randomized controlled trial
Bigseth, T. T., Engh, J. A., Andersen, E., Bang-Kittilsen, G., Egeland, J., Falk, R. S., Holmen, T. L., Mordal, J., Nielsen, Jimmi, Ueland, T., Vang, T. & Fredriksen, M., 2023, In: Frontiers in Psychiatry. 14, 10 p., 1175171.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Antipsychotic prescribing practices for outpatients with schizophrenia and reasons for non-clozapine treatment - Data from a Danish quality assessment audit
Jakobsen, M. I., Schaug, J. P., Nielsen, Jimmi & Simonsen, Erik, 2023, In: Nordic Journal of Psychiatry. 77, 5, p. 481-490 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)
Sass, M. R., Danielsen, A. A., Köhler-Forsberg, O., Storgaard, H., Knop, Filip Krag, Nielsen, Mette Ødegaard, Sjödin, Anders Mikael, Mors, O., Correll, C. U., Ekstrøm, Claus Thorn, Vinberg, Maj, Nielsen, Jimmi, Vilsbøll, Tina & Fink-Jensen, Anders, 2023, In: BMJ Open. 13, 1, 10 p., e068652.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Mental Health Staff’s Perspectives on Tapering of Antipsychotic Medication: A Focus Group Study
Roed, K., Buus, N., Nielsen, Jimmi, Christensen, P. S. & Midtgaard, Julie, 2023, In: Qualitative Health Research. 33, 13, p. 1165–1176 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians’ perspectives
Jakobsen, M. I., Austin, Stephen Fitzgerald, Storebø, O. J., Nielsen, Jimmi & Simonsen, Erik, 2023, In: Schizophrenia. 9, 1, 13 p., 91.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The phenotypic presentation of adult individuals with SLC6A1-related neurodevelopmental disorders
Johannesen, K. M., Nielsen, Jimmi, Sabers, A., Isidor, B., Kattentidt-Mouravieva, A. A., Zieglgänsberger, D., Heidlebaugh, A. R., Oetjens, K. F., Vidal, A. A., Christensen, J., Tiller, J., Freed, A. N., Møller, R. S. & Rubboli, Guido, 2023, In: Frontiers in Neuroscience. 17, 7 p., 1216653.Research output: Contribution to journal › Journal article › Research › peer-review
- 2022
- Published
Use of psychotropic medication and risk of road traffic crashes: a registry-based case-control study in Denmark, 1996-2018
Olesen, A. V., Madsen, T. K. O., Lahrmann, H. & Nielsen, Jimmi, Aug 2022, In: Psychopharmacology. 239, 8, p. 2537-2546 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
de Leon, J., Schoretsanitis, G., Smith, R. L., Molden, E., Solismaa, A., Seppala, N., Kopecek, M., Svancer, P., Olmos, I., Ricciardi, C., Iglesias-Garcia, C., Iglesias-Alonso, A., Spina, E., Ruan, C-J., Wang, C-Y., Wang, G., Tang, Y-L., Lin, S-K., Lane, H-Y., Kim, Y. S. & 84 others, , Mar 2022, In: Pharmacopsychiatry. 55, 02, p. 73-86 14 p.Research output: Contribution to journal › Review › Research › peer-review
ID: 217143987
Most downloads
-
41
downloads
Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry)
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
20
downloads
Clozapine and mortality: A comparison with other antipsychotics in a nationwide Danish cohort study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
17
downloads
Leptin Serum Levels are Associated With GLP-1 Receptor Agonist-Mediated Effects on Glucose Metabolism in Clozapine-or Olanzapine-Treated, Prediabetic, Schizophrenia Patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published